Current and future prospects of the treatment of the irritable bowel syndrome
Garrigues Gil, V.; Ortiz Bellver, V.
Revista Clinica Espanola 203(9): 445-446
2003
ISSN/ISBN: 0014-2565 PMID: 14563260 Document Number: 563743
Document emailed within 1 workday
Related Documents
Uspenskiĭ, I.P.; Fominykh, I.A. 2010: Prospects for using ladasten preparations in patients with irritable bowel syndrome Eksperimental'naia i Klinicheskaia Gastroenterologiia 10: 75-79Basilisco, G. 2007: Pathogenesis of irritable bowel syndrome: current understanding Recenti Progressi in Medicina 98(11): 543-547
Olmos, J. 1995: Irritable bowel syndrome: current therapeutic approach Acta Gastroenterologica Latinoamericana 25(3): 183-184
Friedman, G. 1991: Treatment of the irritable bowel syndrome Gastroenterology Clinics of North America 20(2): 325-333
Csef, H. 1996: Recent psychosomatic contributions to the pathogenesis and therapy of irritable colon (irritable bowel syndrome) Zeitschrift für Gastroenterologie 34(4): 250-255
Barak, N.; Ishai, R.; Lev-Ran, E. 1999: Biofeedback treatment of irritable bowel syndrome Harefuah 137(3-4): 105-7 175
Dalton, C.B.; Drossman, D.A. 1997: Diagnosis and treatment of irritable bowel syndrome American Family Physician 55(3): 875-880; 883-885
Dubinin, A.V.; Kabanov, A.V.; Kirkin, B.V.; Kolkunova, G.K.; Igorianova, N.A. 1987: Bran in the treatment of irritable bowel syndrome Voprosy Pitaniia 1: 13-16
Pérez-Mateo, M.; Sillero, C.; Cuesta, A.; Vazquez, N.; Berbegal, J. 1986: Diltiazem in the treatment of the irritable bowel syndrome International Journal of Clinical Pharmacology Research 6(5): 425-427
Inoue, M. 1992: Pharmaceutical treatment of irritable bowel syndrome Nihon Rinsho. Japanese Journal of Clinical Medicine 50(11): 2746-2751
Shi, H.; Wan, J.; Liu, W.; Su, B. 2015: An analysis for the clinical difference between post infectious irritable bowel syndrome and non post infectious irritable bowel syndrome Zhonghua Nei Ke Za Zhi 54(4): 326-329
Munck, L.K.; Ainsworth, M.A. 2007: Tegaserod in treatment of women with irritable bowel syndrome Ugeskrift for Laeger 169(23): 2190-2192
Giaquinta, D. 2002: Contemporary thoughts on the treatment of irritable bowel syndrome Managed Care Interface 15(8): 19-20; 22
Iwai, A.; Miyahara, T.; Koyama, H.; Niwa, H. 1992: The general aspects of the treatment of irritable bowel syndrome Nihon Rinsho. Japanese Journal of Clinical Medicine 50(11): 2734-2739
Bixquert, M. 2013: Treatment of irritable bowel syndrome with probiotics: growing evidence Indian Journal of Medical Research 138: 175-177
Preobrazhenskiĭ, V.N. 1999: Salozinal in the treatment of the irritable bowel syndrome in young persons Terapevticheskii Arkhiv 71(2): 37-39
Hu, Y.; Tao, L.; Lyu, B. 2015: A meta-analysis of probiotics for the treatment of irritable bowel syndrome Zhonghua Nei Ke Za Zhi 54(5): 445-451
Tofte, R.W.; Williams, D.N. 1981: Toxic shock syndrome: current status and future prospects Minnesota Medicine 64(8): 463-467
Baldi, F.; Longanesi, A.; Blasi, A.; Monello, S.; Cestari, R.; Missale, G.; Corazziari, E.; Badiali, G.; Marzio, L.; Di Felice, F. 1992: Octylonium bromide in the treatment of the irritable bowel syndrome: a clinical-functional study Hepato-Gastroenterology 39(5): 392-395
Lech, Y.; Olesen, K.M.; Hey, H.; Rask-Pedersen, E.; Vilien, M.; Ostergaard, O. 1988: Treatment of irritable bowel syndrome with peppermint oil. a double-blind study with a placebo Ugeskrift for Laeger 150(40): 2388-2389